In addition, based on the potentially pivotal role that dysregulation of AREG and EGFR signaling may play in pulmonary fibrosis pathogenesis, AREG could be a potential therapeutic target for IIM-related ILD. This evidence concerns the gene EGFR and interstitial lung disease.